Mary Ellen Turner MD, MPH Vice-President Global Safety Surveillance & Epidemiology Risk Management: Practical Implications for Pharmaceutical Manufacturers.
FDA Guidance for risk evaluation and mitigation strategies - Professor Peivand Pirouzi
Developing a RiskMAP Louis A. Morris, Ph.D. Pharmaceutical Education Associates December 10, 2004.
